Description
Recombinant Zika Virus-like Particles (Zika VLPs) are produced in mammalian HEK293 human cells, assembled with envelope, pre-Membrane and Membrane protein. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. Zika VLPs can be used in the development of ZIKV diagnostics and in vaccine development and R&D (including use as an immunogen).